Literature DB >> 19896217

Temporal association of large granular lymphocytosis, neutropenia, proviral load, and FasL mRNA in cats with acute feline immunodeficiency virus infection.

W S Sprague1, J A TerWee, S VandeWoude.   

Abstract

During acute feline immunodeficiency virus-C(PGammar) (FIV-C-PG) infection, we observed that cats develop large granular lymphocyte (LGL) lymphocytosis concurrent with a marked neutropenia that is temporally associated with the rise and fall of FIV-C-PG proviral loads. LGLs, generally considered to be analogous to natural killer (NK) cells, can also be highly cytolytic CD8/CD57 T cells. Neutropenia has been reported during acute human immunodeficiency virus (HIV-1) infection, but there is a paucity of information describing the pathogenesis of this condition. During HIV-1 infection, LGLs have been shown to be both CD16(+) NK cells and CD8(+)/CD57(+) T cells, but an association with neutropenia has not been described. However, neutropenia with concurrent LGL lymphocytosis has been demonstrated in both LGL leukemia and common variable immunodeficiency syndrome in people, and in both syndromes, an increase in soluble Fas ligand (FasL) has been associated with neutrophil apoptosis leading to neutropenia. Flow cytometric analysis demonstrated increases in CD56 and CD8 peripheral blood cell surface expression during acute FIV-C-PG infection. Expression of FasL mRNA was increased at the same time points as these peripheral hematologic abnormalities, and also decreased as FIV-C-PG proviral load reached set point. We describe an interesting temporal association between innate immune responses and viral load during acute FIV-C-PG infection, which has similarities to HIV-1 infection and other immune dyscrasias of people, and which may contribute to the neutropenia and LGL lymphocytosis during FIV-C-PG infection. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896217      PMCID: PMC2821998          DOI: 10.1016/j.vetimm.2009.10.016

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  42 in total

1.  Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.

Authors:  F Sabri; A De Milito; R Pirskanen; I Elovaara; L Hagberg; P Cinque; R Price; F Chiodi
Journal:  J Neuroimmunol       Date:  2001-03-01       Impact factor: 3.478

2.  Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals.

Authors:  S Gupta
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

3.  Benign monoclonal expansion of CD8+ lymphocytes in HIV infection.

Authors:  P R Smith; J D Cavenagh; T Milne; D Howe; S J Wilkes; P Sinnott; G E Forster; M Helbert
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

4.  Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia.

Authors:  A M Holm; G Tjønnfjord; A Yndestad; K Beiske; F Müller; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

5.  Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study.

Authors:  Alexandra M Levine; Roksana Karim; Wendy Mack; D Jay Gravink; Katherine Anastos; Mary Young; Mardge Cohen; Meg Newman; Michael Augenbraun; Stephen Gange; D Heather Watts
Journal:  Arch Intern Med       Date:  2006-02-27

6.  Evolution of innate and adaptive effector cell functions during acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Ryan Ahern; Hendrik Streeck; Angela Meier; Eric S Rosenberg; Marcus Altfeld
Journal:  J Infect Dis       Date:  2007-04-10       Impact factor: 5.226

7.  CD3+ CD8+ CD56- clonal large granular lymphocyte leukaemia and HIV infection.

Authors:  M Pulik; F Lionnet; P Genet; C Petitdidier; L Jary; C Fourcade
Journal:  Br J Haematol       Date:  1997-08       Impact factor: 6.998

8.  Mechanisms of neutrophil death in human immunodeficiency virus-infected patients: role of reactive oxygen species, caspases and map kinase pathways.

Authors:  S Salmen; H Montes; A Soyano; D Hernández; L Berrueta
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

9.  Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection.

Authors:  L E Pereira; R P Johnson; A A Ansari
Journal:  Cell Immunol       Date:  2008-07-21       Impact factor: 4.868

10.  Enhanced expression of novel CD57+CD8+ LAK cells from cats infected with feline immunodeficiency virus.

Authors:  Y Zhao; D Gebhard; R English; R Sellon; M Tompkins; W Tompkins
Journal:  J Leukoc Biol       Date:  1995-10       Impact factor: 4.962

View more
  5 in total

1.  Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection.

Authors:  Wendy S Sprague; Cristian Apetrei; Anne C Avery; Robert L Peskind; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2015-07-29       Impact factor: 2.046

Review 2.  Applications of the FIV Model to Study HIV Pathogenesis.

Authors:  Craig Miller; Zaid Abdo; Aaron Ericsson; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

3.  Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.

Authors:  Wendy S Sprague; Ryan M Troyer; Xin Zheng; Britta A Wood; Martha Macmillian; Scott Carver; Susan VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

Review 4.  Immunodeficiencies caused by infectious diseases.

Authors:  Jane E Sykes
Journal:  Vet Clin North Am Small Anim Pract       Date:  2010-05       Impact factor: 2.093

5.  Diversity of trends of viremia and T-cell markers in experimental acute feline immunodeficiency virus infection.

Authors:  Sylvain Roche; Hanane El Garch; Sylvie Brunet; Hervé Poulet; Jean Iwaz; René Ecochard; Philippe Vanhems
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.